222 related articles for article (PubMed ID: 15072828)
1. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity.
Berstein LM; Imyanitov EN; Kovalevskij AJ; Maximov SJ; Vasilyev DA; Buslov KG; Sokolenko AP; Iyevleva AG; Chekmariova EV; Thijssen JH
Cancer Lett; 2004 Apr; 207(2):191-6. PubMed ID: 15072828
[TBL] [Abstract][Full Text] [Related]
2. Hormonal imbalance in two types of endometrial cancer and genetic polymorphism of steroidogenic enzymes.
Berstein L; Zimarina T; Imyanitov E; Kovalevskij A; Maximov S; Pujol P; Thijssen J
Maturitas; 2006 Jul; 54(4):352-5. PubMed ID: 16730930
[TBL] [Abstract][Full Text] [Related]
3. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
[TBL] [Abstract][Full Text] [Related]
4. CYP19 gene polymorphism in endometrial cancer patients.
Berstein LM; Imyanitov EN; Suspitsin EN; Grigoriev MY; Sokolov EP; Togo A; Hanson KP; Poroshina TE; Vasiljev DA; Kovalevskij AY; Gamajunova VB
J Cancer Res Clin Oncol; 2001 Feb; 127(2):135-8. PubMed ID: 11216915
[TBL] [Abstract][Full Text] [Related]
5. The T/C polymorphism of the CYP17 gene and G/A polymorphism of the CYP19 gene in endometrial cancer.
Szyllo K; Smolarz B; Romanowicz-Makowska H; Lewy J; Kulig B
J Exp Clin Cancer Res; 2006 Sep; 25(3):411-6. PubMed ID: 17167982
[TBL] [Abstract][Full Text] [Related]
6. The polymorphisms of the CYP17 and CYP19 genes in endometrial cancer patients.
Szyłło K; Smolarz B; Romanowicz-Makowska H; Kulig A
Pol J Pathol; 2006; 57(1):35-40. PubMed ID: 16739881
[TBL] [Abstract][Full Text] [Related]
7. CYP17 genetic polymorphism in endometrial cancer: are only steroids involved?
Berstein LM; Imyanitov EN; Gamajunova VB; Kovalevskij AJ; Kuligina ESh; Belogubova EV; Buslov KG; Karpova MB; Togo AV; Volkov ON; Kovalenko IG
Cancer Lett; 2002 Jun; 180(1):47-53. PubMed ID: 11911969
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
[TBL] [Abstract][Full Text] [Related]
9. [Genetic polymorphism of steroid 17 alpha-hydroxylase/17,20-lyase (CYP17) and hyperinsulinemia in endometrial carcinoma].
Berstein LM; Imianitov EN; Gamaiunova VB; Kovalevskiĭ AIu; Kuligina ESh; Belogubova EV; Buslov KG; Karpova MB; Togo AV; Volkov ON; Kovalenko IG; Chernobrovkina AE
Vopr Onkol; 2002; 48(6):673-8. PubMed ID: 12530262
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
[TBL] [Abstract][Full Text] [Related]
11. [Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system].
Berstein LM; Zimarina TS; Tsyrlina EV; Kovalevskiĭ AIu; Imianitov EN
Vopr Onkol; 2004; 50(2):169-73. PubMed ID: 15176218
[TBL] [Abstract][Full Text] [Related]
12. Association of serum sex steroid levels and bone mineral density with CYP17 and CYP19 gene polymorphisms in postmenopausal women in Turkey.
Yilmaz MB; Pazarbasi A; Guzel AI; Kocaturk-Sel S; Kasap H; Kasap M; Urunsak IF; Basaran S; Alptekin D; Demirhan O
Genet Mol Res; 2011 Sep; 10(3):1999-2008. PubMed ID: 21948762
[TBL] [Abstract][Full Text] [Related]
13. A polymorphism in CYP17 and endometrial cancer risk.
Haiman CA; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Res; 2001 May; 61(10):3955-60. PubMed ID: 11358812
[TBL] [Abstract][Full Text] [Related]
14. [Association of polymorphism of genetic markers of CYP19 and CYP17 with sporadic breast cancer].
Artamonov VV; Liubchenko LN; Shabanov MA; Babenko OV; Nemtsova MV; Zaletaev DV
Mol Biol (Mosk); 2003; 37(6):975-82. PubMed ID: 14714492
[TBL] [Abstract][Full Text] [Related]
15. CYP19 (aromatase) haplotypes and endometrial cancer risk.
Paynter RA; Hankinson SE; Colditz GA; Kraft P; Hunter DJ; De Vivo I
Int J Cancer; 2005 Aug; 116(2):267-74. PubMed ID: 15800924
[TBL] [Abstract][Full Text] [Related]
16. [A polymorphism study of the CYP19 gene in endometrial cancer patients].
Bershteĭn LM; Imianitov EN; Suspitsyn EN; Grigor'ev MIu; Sokolov EP; Togo AV; Khanson KP; Poroshina TE; Gamaiunova VB; Vasil'ev DA; Kovalevskiĭ AIu; Volkov ON
Vopr Onkol; 2000; 46(3):302-5. PubMed ID: 10976276
[TBL] [Abstract][Full Text] [Related]
17. Are the T/C polymorphism of the CYP17 gene and the tetranucleotide repeat (TTTA) polymorphism of the CYP19 gene genetic markers for premature coronary artery disease in Caucasians?
Letonja M; Peterlin B; Bregar D; Petrovic D
Folia Biol (Praha); 2005; 51(3):76-81. PubMed ID: 16045239
[TBL] [Abstract][Full Text] [Related]
18. Impact of constitutional genetic variation in androgen/oestrogen-regulating genes on age-related changes in human prostate.
Azzouzi AR; Cochand-Priollet B; Mangin P; Fournier G; Berthon P; Latil A; Cussenot O
Eur J Endocrinol; 2002 Oct; 147(4):479-84. PubMed ID: 12370109
[TBL] [Abstract][Full Text] [Related]
19. [A case-control study on genetic polymorphism of CYP17 MspA(1)I and its association with endometrial cancer risk].
Gao J; Xiang YB; Xu WH; Cheng JR; Cai QY; Shu XO; Gao YT
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):266-9. PubMed ID: 17760252
[TBL] [Abstract][Full Text] [Related]
20. Polymorphic variants of CYP17 and CYP19A and risk of infertility in endometriosis.
Szczepańska M; Wirstlein P; Skrzypczak J; Jagodziński PP
Acta Obstet Gynecol Scand; 2013 Oct; 92(10):1188-93. PubMed ID: 23809139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
